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Abstract
Background: A. baumannii is becoming a common opportunistic and nosocomial 
pathogen in ICUs worldwide. Few studies have investigated the epidemiology of A. 
baumannii isolates colonizing the respiratory tract of hospitalized patients in ICUs.
Methods: A total of 93 patients admitted to various intensive care unites (ICUs) 
over a period of 10-month at the Jordan University Hospital (JUH) were investigated 
for colonizing their respiratory tract with A. baumannii. Risk factors for respira-
tory colonization with A. baumannii were determined. All A. baumannii isolates 
were examined for their antimicrobial susceptibility pattern, presence of specific 
β-lactamase genes and common genotypes using enterobacterial repetitive inter-
genic consensus sequences (ERICs) and PCR.
Results: Two third of hospitalized patients (63/93; 67.7 %) have their respiratory 
tract colonized with A. baumannii, and significant risk factors associated with 
colonization were longer ICU stay, use of mechanical ventilators and antibiotic 
treatment with carbapenems. All A. baumannii isolates were multidrug resistant 
(MRAB) and possessed blaOXA-51-like gene; in addition, 73% and 19% of the 
isolates harbored blaOXA-23-like and blaOXA-24-like genes, respectively. All iso-
lates were negative for MBL-encoding gene (blaIMP-1) and only two isolates (3%) 
harbored (blaVIM-2) gene. The genetic similarity of A. baumannii isolates using 
ERICs-PCR and constructed dendrogram showed 2 major genotype clusters of 
genetically related isolates.
Conclusion: This study shows that few genotypes of MRAB are often colonizing 
the respiratory tract of hospitalized patients in ICUs, and colonization was rarely 
associated with blood sepsis and mortality.
This article is available from: 
www.iajaa.org
Introduction
Acinetobacter baumannii has emerged as an important noso-
comial opportunistic pathogen in intensive care units (ICUs) 
worldwide (1-4). The organism’s ability to survive for extend-
ed periods on inanimate surfaces and by the presence of hu-
midity conditions allows its existence as a potential pathogen 
in the hospital environment and its numerous spread among 
hospitalized patients (4-5).
A. baumannii causes generally ventilator-associated pneu-
monia, septicemia, and surgical site infection in hospitalized 
patients (3). It has been also reported that extensive usage of 
broad-spectrum antibiotics in hospitals was associated with 
increased incidence of multidrug resistance A. baumannii 
(MRAB) rates, specifically to carbapenems (4).
Additional risk factors for the acquisition of MRAB infection 
or colonization included longer hospitalization stay, admis-
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sion to ICUs, use of mechanical ventilation, wound irrigation, 
blood sepsis and increased mortality (2,6). The potential of 
MRAB strains to colonize the respiratory tract seems depend 
on the expression of specific virulence factors, especially pro-
duction of biofilm and adherence to epithelial cell surfaces 
(4,7).
This prospective study investigated the incidence rate, risk 
factors, antimicrobial resistance profiles and common geno-
types of A. baumannii colonizing respiratory tract of ICU pa-
tients over a 10-month period.
Methods
Patients
A total of 142 respiratory samples (bronchoalveolar lavage, 
tracheal aspirate and sputum) were consecutively collected 
from 93 patients admitted to intensive care units (ICUs), Jor-
dan University Hospital (JUH) over a 10-month period (May 
2009-Febreuary 2010). For all patients; the name, age, sex, 
clinical diagnosis, type of antibiotics administered, mechani-
cal ventilation, length of ICU stay, presence of tracheotomy, 
developing blood sepsis and mortality were recorded. This 
study was proved by Independent Research Ethics Review 
(IRB) no. L29/2009, Jordan University Hospital.
Sample processing
All collected samples were cultured on blood agar, CLED agar, 
and minimal-salt agar supplemented with 1% acetate (MSA) 
for detection of colonization with Acinetobacter spp. All sus-
pected Acinetobacter growing colonies were first identified 
by conventional techniques and confirmed later as A. bau-
mannii by Rapid NF plus system, Remel Kit (USA). Only one 
positive culture was included for each patient, and all isolates 
were stored in brain-heart infusion agar plus 15% glycerol at 
-70 °C until tested.
Antimicrobial susceptibility testing
A. baumannii isolates were tested against 11 antimicrobial 
agents (Table 2) using disc diffusion method according to the 
guidelines of CLSI, 2009 (8). Minimum inhibitory concentra-
tions (MICs) were determined by E-test (AB Biodisk, Solna, 
Sweden) for imipenem, amikacin, tigecycline, and colistin. 
Pseudomonas aeruginosa ATCC 27853 was used as quality 
control strain.
Detection of β-lactamase genes
The genomic DNA was extracted from overnight cultures of 
A. baumannii isolates in brain heart infusion broth using the 
Wizard Genomic DNA purification kit (Promega, USA). A mul-
tiplex was used to identify metalo-beta-Lactamases (VIM-2, 
IMP-1) and OXA type β-lactamase genes (OXA-58, OXA-51, 
OXA-24 ,OXA-23) as described by Sung et al. (9).
Enterobacterial repetitive intergenic consensus 
(ERIC)-PCR typing
DNA fingerprinting was performed using ERIC-PCR method 
with primers ERIC1 and ERIC2 as previously described by Ver-
salovic et al.(10). Amplification conditions were 95°C for 5 
min; 30 cycles of 50 sec at 92°C, 55 sec at 52 °C and 7 min 
at 70 °C with a final step at 70 °C for 10 min. PCR products 
were detected in 2% agarose gel.
Statistical analysis
All data were analyzed using the computerized statistical 
analysis (SPSS, version 16). p value <0.05 was considered 
statistically significant.
Results
A total of 63/93 (67.7 %) of ICU patients has their respiratory 
tract colonized by A. baumannii. Only one patient died fol-
lowing developing blood sepsis due to infection / colonization 
with A. baumannii during the study period. Demographic 
data of patients show the common risk factors associated 
with A. baumannii colonization/infection (Table 1). The an-
timicrobial susceptibility pattern of 64 A. baumannii isolates 
including one blood isolates from the same patient is shown 
in Table 2. The susceptibility results for 11 tested agents 
ranged between 63% and 100%, and 58/64 (89%) of the 
isolates were multidrug resistant to at least for 6 tested anti-
microbial agents. There was no resistance observed to both 
tigecycline and colistin. The MIC90 and MIC range to ami-
kacin, imipenem, colistin and tigecycline are shown in Table 
2. The distribution of β-lactamases genes among 64 A. bau-
mannii isolates is shown in Table 3. All isolates possessed the 
encoding gene for an intrinsic OXA-51 carbapenemase, 73% 
were positive for blaOXA-23-like gene, and 19% were posi-
tive for blaOXA-24-like gene. None of the isolates harbored 
blaOXA-58-like or MBL-encoding gene (blaIMP-1) and Only 
two isolates(3%) harbored (blaVIM-2) gene.Two major clus-
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Variables No. (%) colonizedpatients 
No. (%) not-colonized 
patients P-value
Total of patients* 63 (67.7) 30 (32.3) <0.001
Gender
0.344Male 36 (72.0) 14 (28.0)
Female 27 (62.8) 16 (37.2) 
Mean age 60.17 ±18.993 58.1±19.971 0.629
Length of stay in ICU 7.51 ± 1.595 2.73 ± 2.37 < 0.001
1-3 days 1 (3.7) 26 (96.3)
 < 0.0014-8 days 56 (94.9) 3 (5.1)
> 8 days 6 (85.7) 1 (14.3) 
Antibiotics treatment** treatment
< 0.001Yes 53 (81.5) 12 (18.5)
No 10 (35.7) 18 (64.3)
Mechanical ventilation
<0.001Yes 60 (84.5) 11 (15.5)
No 3 (13.6) 19 (86.4)
Length of ventilation (mean±std) 5.02 ± 1.17 1.36 ± 0.67 <0.001
Tracheostomy 
0.347Yes 11 (78.6) 3 (21.4)
No 52 (65.8)  27 (34.2)
Table 1.  Major demographic characteristics of 93 adult patients admitted to ICUs and examined for respiratory tract colo-
nization with A .baumannii.
  *  All underlying diseases in patients were not significant for respiratory tract colonization with A.baumanni, and only one male pa-
tient was colonized and developed fatal blood sepsis with the same strain. 
**  Most patients (77%) were treated only with carbapenems during their stay in ICUs. 
Antimicrobial No. (%) Resistant isolates* MIC90 (mg/L) MIC-range (mg/L)
Ceftazidime (Caz) 64 (100)  ND **  ND
Ertapenem (Etp) 64 (100) ND ND
Meropenem (Mem) 64 (100) ND ND
Piperacillin/Tazobactam
(Ptz) 63 (98) ND ND
Aztreonam (Atm) 63 (98) ND ND
Gentamicin (Gm) 60 (94) ND ND
Ciprofloxacin  58 (91) ND ND
Amikacin (Ak) 47 (73) 13.6 1-16
Imipenem (Imi) 40 (63) 12 0.19-12
Colistin (Co) 0 (0) 1 0.19-1
Tigecycline (Tgc) 0 (0) 2 0.38-4
Table 2. Antimicrobial resistance patterns of 64 A. baumannii isolates from 63 ICU patients.
* ND = Not done.
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ters of few genotypes were detected among 64 A. baumannii 
isolates The majority of isolates (46/64; 71.9%) showed 4-6 
DNA fragments ranged between 500-3000bp (Table 4 and 
Fig. 1). On the basis of similarity index of constructed dendro-
gram, 71.9% of the isolates are suggesting to be one clone.
Discussion
This study found that about two third (67.7%) of hospital-
ized patients in various ICUs at JUH in Amman, have their 
respiratory tract colonized with A. baumannii. Major demo-
graphic characters of patients were incorporated for mul-
tivariate analysis which revealed that antibiotics treatment, 
the longer duration of mechanical ventilation and stay in the 
ICUs (P<0.05) were significant independent risk factors for 
colonization with A. baumannii.
In particular, antibiotic treatment with carbapenems has been 
shown to be mostly associated with respiratory tract coloni-
β-lactamases Type of β-lactamase Prevalence (%)
Class B
IMP 0 (0)
VIM 2 (3)
Class D
OXA-51 64 (100)
OXA-23 47(73)
OXA-24 12 (19)
OXA-58 0 (0)
Major 
cluster genotype
Size of common 
DNA fragments(bp)
No. of 
isolates
1st
1 500-1500 23
2 600-2000 16
3 200-3000 7
2nd 1 700-1500 18
Table 3.  Prevalence of β-lactamases among 64 A. bauman-
nii isolates. 
Table 4.  Genotyping of 64 clinical A. baumannii isolates 
based on constructed dendrogram.
zation. In addition, none of the clinical diseases diagnosed 
in our patients was a significant risk factor for A.baumannii 
respiratory tract colonization (Table 1). Previous studies from 
different parts of the world have demonstrated that some 
or most of these risk factors were responsible for develop-
ing colonization/infection with A. baumannii in ICU patients 
(4,11-13). However, our study observed that only one fatal 
case of blood sepsis due to A. baumannii might be associ-
ated with respiratory colonization, and was initiated by using 
mechanical ventilation. Since antimicrobial resistance pattern 
of both A. baumannii isolates and their molecular typing by 
ERIC-PCR generated DNA fragments suggest that both iso-
lates were similar and might be originated from the same 
clone. Other recent studies have reported higher blood sepsis 
and mortality rates in association with MDR A. baumannii in 
hospitalized patients (3,6,13-14).
The present study showed high resistance rates of A. bau-
mannii isolates to many used antimicrobial agents in Jordan, 
except to colistin and tigecycline. The majority of A. bau-
mannii isolates (89%) in this study were multidrug resistant 
( resistance to more than 6 tested drugs) as shown in Table 
2. Recently, numerous studies worldwide reported high in-
cidence of antimicrobial resistance rates among clinical A. 
baumannii isolates, but resistance to colistin was absent or 
rarely observed as it has been demonstrated in our study 
(1-2,15-18).
Carbapenems are among the drugs of choice used to treat 
nosocomial infections caused by MDR A. baumannii, and 
carbapenems were used frequently in treatment of our ICU 
patients. However, emergence of resistance to carbapenems 
causes serious concern in hospitalized patients and should be 
monitored (1,4). The naturally occurring β-lactamases have 
been identified as a source of carbapenem resistance in A. 
baumannii.
These enzymes belong either to the class B, or to the class 
D oxacillinase (19). Regardless of their susceptibility to car-
bapenems, all A. baumannii isolate produced the blaOXA-
51-like gene. This result confirm other studies which have 
suggested that blaOXA-51-like gene is species-specific to 
A. baumannii (16-17,20), and it was proposed that studies 
of A.baumannii epidemiology could involve initial screen-
ing of blaOXA-51-like alleles to identify isolates belonging 
to major epidemic clones(21). The findings of this study also 
indicated that OXA-23 carbapenemase was predominant, 
whereas OXA-24 carbapenemase was less common. Other 
studies found also that many of A. baumannii isolates have 
acquired OXA-23 carbapenemase (18-19,22-23). The overall 
genetic relatedness of 64 A. baumannii isolates using ERIC-
PCR and a constructed dendrogram showed 2 major clusters 
(clones); one cluster accounted for 71.9% of all A. baumannii 
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Figure 1. Dendrogram of 64 A. baumannii isolates.
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isolates (Figure 1). This cluster was divided into 3 common 
genotypes assigned as genotype 1, 2 and 3 (Table 4). These 
findings suggest that A. baumannii strains originated from 
two clones have been successfully circulated between ICU 
patients at the JUH during the study period, and may indi-
cate cross transmission within the ICU setting. Various studies 
have demonstrated that ERIC-PCR method proved to be a 
useful to detect clones with acceptable reproducibility and 
discrimination index among certain Gram-negative bacterial 
strains including A. baumannii (9,224-25).
In conclusion, this study demonstrates that patients in ICUs 
are frequently colonized with few predominant genotypes of 
multidrug resistance A. baumannii. 
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